Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cytomegalovirus | 17 | 2022 | 754 | 1.780 |
Why?
|
Cytomegalovirus Infections | 16 | 2022 | 839 | 1.520 |
Why?
|
Antiviral Agents | 42 | 2022 | 3064 | 1.420 |
Why?
|
Simplexvirus | 41 | 2002 | 805 | 1.270 |
Why?
|
Acyclovir | 34 | 2004 | 267 | 1.250 |
Why?
|
Ganciclovir | 20 | 2022 | 256 | 1.190 |
Why?
|
HIV-1 | 30 | 2022 | 6963 | 1.030 |
Why?
|
Virus Replication | 23 | 2011 | 2458 | 0.720 |
Why?
|
HIV Infections | 27 | 2023 | 17575 | 0.680 |
Why?
|
Viral Vaccines | 5 | 2023 | 596 | 0.640 |
Why?
|
Drug Resistance, Microbial | 31 | 2001 | 830 | 0.620 |
Why?
|
HIV Reverse Transcriptase | 7 | 2011 | 214 | 0.620 |
Why?
|
RNA, Viral | 20 | 2009 | 2866 | 0.550 |
Why?
|
Anti-HIV Agents | 10 | 2012 | 4571 | 0.520 |
Why?
|
DNA-Directed DNA Polymerase | 17 | 2003 | 481 | 0.510 |
Why?
|
Herpesviridae Infections | 4 | 2009 | 269 | 0.510 |
Why?
|
Herpes Zoster | 6 | 2011 | 252 | 0.480 |
Why?
|
Didanosine | 8 | 1997 | 151 | 0.470 |
Why?
|
Acquired Immunodeficiency Syndrome | 20 | 2009 | 2202 | 0.470 |
Why?
|
Zidovudine | 12 | 1996 | 625 | 0.460 |
Why?
|
DNA, Viral | 27 | 2009 | 2205 | 0.450 |
Why?
|
Genes, Viral | 13 | 1993 | 655 | 0.430 |
Why?
|
Guanine | 15 | 1996 | 280 | 0.410 |
Why?
|
Herpes Simplex | 9 | 2002 | 470 | 0.410 |
Why?
|
HIV Long Terminal Repeat | 3 | 2022 | 86 | 0.400 |
Why?
|
Catholicism | 1 | 2011 | 33 | 0.380 |
Why?
|
Gene Products, gag | 2 | 2002 | 317 | 0.360 |
Why?
|
Herpes Genitalis | 6 | 2011 | 149 | 0.350 |
Why?
|
Viral Proteins | 9 | 2003 | 1802 | 0.350 |
Why?
|
Ribavirin | 8 | 1996 | 395 | 0.330 |
Why?
|
Phosphonoacetic Acid | 11 | 1992 | 54 | 0.330 |
Why?
|
Chlorobenzenes | 2 | 2000 | 31 | 0.330 |
Why?
|
Herpesvirus 2, Human | 3 | 2011 | 191 | 0.320 |
Why?
|
Muromegalovirus | 1 | 2009 | 31 | 0.320 |
Why?
|
HIV | 6 | 2010 | 1596 | 0.320 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2007 | 379 | 0.310 |
Why?
|
Capsid | 2 | 2002 | 435 | 0.310 |
Why?
|
Naphthalenes | 2 | 2000 | 198 | 0.310 |
Why?
|
Capsid Proteins | 2 | 2002 | 468 | 0.300 |
Why?
|
Hematopoietic Stem Cells | 4 | 2010 | 3407 | 0.280 |
Why?
|
Leukocytes, Mononuclear | 7 | 2011 | 1855 | 0.270 |
Why?
|
Herpesviridae | 5 | 1992 | 104 | 0.270 |
Why?
|
Valine | 3 | 2004 | 410 | 0.270 |
Why?
|
Herpesvirus 8, Human | 1 | 2008 | 256 | 0.270 |
Why?
|
Viral Envelope Proteins | 2 | 2004 | 641 | 0.260 |
Why?
|
Coronavirus Infections | 1 | 2023 | 3118 | 0.260 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2012 | 1903 | 0.260 |
Why?
|
Thymidine Kinase | 13 | 2000 | 286 | 0.250 |
Why?
|
Ribonucleosides | 5 | 1988 | 79 | 0.240 |
Why?
|
Diphtheria Toxin | 2 | 1997 | 253 | 0.230 |
Why?
|
Foscarnet | 7 | 2003 | 36 | 0.230 |
Why?
|
AIDS-Related Opportunistic Infections | 7 | 2009 | 664 | 0.220 |
Why?
|
Drug Resistance, Viral | 3 | 2022 | 869 | 0.210 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 2 | 2022 | 434 | 0.210 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2003 | 65 | 0.210 |
Why?
|
Nucleocapsid Proteins | 1 | 2002 | 75 | 0.200 |
Why?
|
Viral Structural Proteins | 3 | 1991 | 93 | 0.200 |
Why?
|
Organophosphorus Compounds | 4 | 1989 | 207 | 0.190 |
Why?
|
Myocarditis | 12 | 2005 | 803 | 0.190 |
Why?
|
Chromatin | 2 | 2023 | 2968 | 0.180 |
Why?
|
Cell Fusion | 1 | 2000 | 294 | 0.170 |
Why?
|
Endocarditis, Bacterial | 3 | 1994 | 436 | 0.160 |
Why?
|
Immunoglobulin G | 2 | 2010 | 4570 | 0.160 |
Why?
|
Immunocompromised Host | 1 | 2004 | 863 | 0.160 |
Why?
|
Encephalomyocarditis virus | 6 | 2005 | 21 | 0.160 |
Why?
|
Polymerase Chain Reaction | 9 | 2009 | 6085 | 0.150 |
Why?
|
Disease Transmission, Infectious | 1 | 2004 | 562 | 0.150 |
Why?
|
Interleukin-2 | 2 | 1997 | 1894 | 0.150 |
Why?
|
Opportunistic Infections | 3 | 1991 | 375 | 0.150 |
Why?
|
RNA Splicing | 1 | 2002 | 903 | 0.150 |
Why?
|
Herpesvirus 1, Human | 1 | 2003 | 744 | 0.150 |
Why?
|
Humans | 119 | 2023 | 768393 | 0.140 |
Why?
|
Herpes Labialis | 5 | 1984 | 28 | 0.140 |
Why?
|
Topoisomerase I Inhibitors | 1 | 1997 | 70 | 0.140 |
Why?
|
2-Aminopurine | 1 | 1996 | 11 | 0.140 |
Why?
|
HIV Core Protein p24 | 6 | 2011 | 247 | 0.140 |
Why?
|
Multipotent Stem Cells | 2 | 2010 | 200 | 0.140 |
Why?
|
DNA Helicases | 1 | 2002 | 853 | 0.140 |
Why?
|
RNA, Messenger | 5 | 2007 | 12805 | 0.130 |
Why?
|
Mutation | 22 | 2022 | 30228 | 0.130 |
Why?
|
HIV Seropositivity | 2 | 2001 | 962 | 0.130 |
Why?
|
Acute-Phase Proteins | 1 | 1997 | 251 | 0.130 |
Why?
|
Camptothecin | 2 | 1997 | 593 | 0.130 |
Why?
|
Vidarabine | 4 | 1991 | 337 | 0.130 |
Why?
|
Enterovirus Infections | 5 | 1989 | 74 | 0.130 |
Why?
|
Coxsackievirus Infections | 5 | 1989 | 45 | 0.130 |
Why?
|
Chickenpox | 3 | 1990 | 96 | 0.120 |
Why?
|
Amino Acid Substitution | 4 | 2011 | 1742 | 0.120 |
Why?
|
Base Sequence | 10 | 2007 | 12422 | 0.120 |
Why?
|
Cardiovirus Infections | 2 | 2005 | 20 | 0.110 |
Why?
|
Cytomegalovirus Retinitis | 3 | 2003 | 56 | 0.110 |
Why?
|
CD4 Lymphocyte Count | 9 | 2009 | 2596 | 0.110 |
Why?
|
Neomycin | 1 | 1993 | 94 | 0.110 |
Why?
|
Blood Pressure | 1 | 2009 | 8541 | 0.110 |
Why?
|
Virus Diseases | 4 | 1995 | 723 | 0.110 |
Why?
|
Skin Diseases, Infectious | 2 | 1990 | 75 | 0.100 |
Why?
|
Virus Integration | 2 | 2007 | 306 | 0.100 |
Why?
|
Viremia | 3 | 2009 | 725 | 0.100 |
Why?
|
Cell Transformation, Viral | 6 | 1985 | 530 | 0.100 |
Why?
|
Cell Line | 18 | 2009 | 15597 | 0.100 |
Why?
|
Pyrrolidinones | 2 | 2009 | 116 | 0.100 |
Why?
|
Antibodies, Viral | 7 | 2003 | 3211 | 0.100 |
Why?
|
Viral Hepatitis Vaccines | 3 | 1986 | 72 | 0.100 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 1992 | 109 | 0.100 |
Why?
|
Reverse Transcriptase Inhibitors | 4 | 1999 | 622 | 0.100 |
Why?
|
Chemotactic Factors | 1 | 1992 | 197 | 0.090 |
Why?
|
Bromodeoxyuridine | 4 | 1987 | 310 | 0.090 |
Why?
|
Cells, Cultured | 13 | 2011 | 19022 | 0.090 |
Why?
|
Inflammation | 1 | 2010 | 10863 | 0.090 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 2 | 2002 | 215 | 0.090 |
Why?
|
Hematoporphyrins | 2 | 1980 | 23 | 0.090 |
Why?
|
Antigens, CD34 | 2 | 2010 | 656 | 0.090 |
Why?
|
AIDS-Related Complex | 3 | 1994 | 107 | 0.090 |
Why?
|
DNA Replication | 6 | 2002 | 1428 | 0.090 |
Why?
|
Chemokines, CXC | 1 | 1992 | 420 | 0.090 |
Why?
|
Drug Interactions | 5 | 1996 | 1420 | 0.080 |
Why?
|
Cytokines | 3 | 2009 | 7445 | 0.080 |
Why?
|
Cytarabine | 4 | 1986 | 697 | 0.080 |
Why?
|
Growth Substances | 1 | 1992 | 761 | 0.080 |
Why?
|
Gene Expression | 4 | 2005 | 7598 | 0.080 |
Why?
|
Diet, Atherogenic | 1 | 2009 | 92 | 0.080 |
Why?
|
Light | 3 | 1980 | 1354 | 0.080 |
Why?
|
Indoles | 1 | 1997 | 1825 | 0.080 |
Why?
|
Methylene Blue | 2 | 1980 | 156 | 0.080 |
Why?
|
RNA Probes | 3 | 1995 | 111 | 0.080 |
Why?
|
DNA Polymerase I | 1 | 1988 | 44 | 0.080 |
Why?
|
Electricity | 2 | 1980 | 176 | 0.080 |
Why?
|
Microbial Sensitivity Tests | 7 | 2003 | 1961 | 0.080 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 3827 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 1997 | 4357 | 0.080 |
Why?
|
Antigens, Viral | 6 | 1998 | 992 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 1997 | 2276 | 0.070 |
Why?
|
Cyclic GMP | 2 | 1985 | 394 | 0.070 |
Why?
|
Hybridization, Genetic | 6 | 1973 | 102 | 0.070 |
Why?
|
Leucine | 2 | 1999 | 548 | 0.070 |
Why?
|
Renin | 1 | 2009 | 648 | 0.070 |
Why?
|
Genes | 3 | 1984 | 1824 | 0.070 |
Why?
|
Lymphocytes | 6 | 1995 | 2611 | 0.070 |
Why?
|
Simian virus 40 | 6 | 1973 | 292 | 0.070 |
Why?
|
Polyradiculopathy | 1 | 1986 | 23 | 0.070 |
Why?
|
Organic Chemicals | 1 | 2007 | 211 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 1997 | 3722 | 0.070 |
Why?
|
Sulfamethoxazole | 1 | 1986 | 51 | 0.070 |
Why?
|
Protein Biosynthesis | 4 | 1993 | 2094 | 0.070 |
Why?
|
Trimethoprim | 1 | 1986 | 79 | 0.070 |
Why?
|
Angiotensin II | 1 | 2009 | 847 | 0.070 |
Why?
|
California | 1 | 2010 | 1443 | 0.070 |
Why?
|
Enterovirus B, Human | 4 | 1988 | 49 | 0.070 |
Why?
|
Plasmids | 5 | 2000 | 2268 | 0.060 |
Why?
|
Hepatitis B | 3 | 1986 | 708 | 0.060 |
Why?
|
Vero Cells | 6 | 2011 | 486 | 0.060 |
Why?
|
Phenotype | 3 | 2022 | 16721 | 0.060 |
Why?
|
HIV Integrase Inhibitors | 1 | 2007 | 165 | 0.060 |
Why?
|
Viruses | 1 | 1989 | 373 | 0.060 |
Why?
|
Adrenergic Agonists | 1 | 2005 | 57 | 0.060 |
Why?
|
Tumor Cells, Cultured | 3 | 2002 | 6132 | 0.060 |
Why?
|
Animals | 45 | 2011 | 169337 | 0.060 |
Why?
|
Immunization, Passive | 2 | 2003 | 619 | 0.060 |
Why?
|
Male | 53 | 2012 | 364902 | 0.060 |
Why?
|
Gene Expression Regulation, Viral | 2 | 2000 | 435 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 1992 | 1658 | 0.060 |
Why?
|
Double-Blind Method | 12 | 2009 | 12456 | 0.060 |
Why?
|
Cardiovascular Diseases | 1 | 2010 | 15649 | 0.060 |
Why?
|
Molecular Sequence Data | 5 | 2001 | 17626 | 0.060 |
Why?
|
RNA-Directed DNA Polymerase | 3 | 1995 | 223 | 0.060 |
Why?
|
Epinephrine | 2 | 2005 | 794 | 0.060 |
Why?
|
Ataxia | 1 | 1986 | 307 | 0.050 |
Why?
|
Viral Load | 4 | 2003 | 3398 | 0.050 |
Why?
|
Pandemics | 1 | 2023 | 8753 | 0.050 |
Why?
|
Propranolol | 1 | 2005 | 493 | 0.050 |
Why?
|
Blood Vessels | 1 | 2009 | 1110 | 0.050 |
Why?
|
Occupational Diseases | 3 | 1986 | 1490 | 0.050 |
Why?
|
Lamivudine | 2 | 2007 | 367 | 0.050 |
Why?
|
Adenoviridae | 6 | 1973 | 1096 | 0.050 |
Why?
|
Cell Division | 4 | 1993 | 4479 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3438 | 0.050 |
Why?
|
Colombia | 1 | 2003 | 287 | 0.050 |
Why?
|
Transduction, Genetic | 1 | 2005 | 902 | 0.050 |
Why?
|
Interferon-alpha | 1 | 2007 | 910 | 0.050 |
Why?
|
Cloning, Molecular | 5 | 1993 | 4168 | 0.050 |
Why?
|
Proviruses | 2 | 2011 | 320 | 0.050 |
Why?
|
Antibodies, Heterophile | 1 | 1982 | 128 | 0.050 |
Why?
|
Genes, rev | 1 | 2001 | 13 | 0.050 |
Why?
|
Genes, tat | 1 | 2001 | 15 | 0.050 |
Why?
|
Infectious Mononucleosis | 1 | 1982 | 133 | 0.050 |
Why?
|
Genes, nef | 1 | 2001 | 52 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3813 | 0.050 |
Why?
|
DNA Primase | 1 | 2002 | 110 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2011 | 2593 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 3 | 1997 | 3731 | 0.050 |
Why?
|
Genetic Complementation Test | 4 | 1988 | 557 | 0.050 |
Why?
|
Spinal Puncture | 1 | 2003 | 286 | 0.050 |
Why?
|
Recombination, Genetic | 5 | 1993 | 1526 | 0.050 |
Why?
|
Aorta | 1 | 2009 | 2046 | 0.050 |
Why?
|
Flow Cytometry | 4 | 2005 | 5900 | 0.050 |
Why?
|
Stomatitis, Herpetic | 2 | 1991 | 12 | 0.050 |
Why?
|
Thymidine | 6 | 1987 | 297 | 0.040 |
Why?
|
RNA, Small Interfering | 2 | 2007 | 3434 | 0.040 |
Why?
|
Ultraviolet Rays | 4 | 1987 | 1100 | 0.040 |
Why?
|
Female | 38 | 2012 | 397089 | 0.040 |
Why?
|
Blotting, Northern | 2 | 1992 | 1553 | 0.040 |
Why?
|
Mice | 24 | 2011 | 82017 | 0.040 |
Why?
|
Adult | 36 | 2009 | 223640 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 1988 | 2709 | 0.040 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 2000 | 221 | 0.040 |
Why?
|
Maternal-Fetal Exchange | 1 | 1982 | 462 | 0.040 |
Why?
|
Mice, Inbred BALB C | 6 | 2011 | 6234 | 0.040 |
Why?
|
Codon | 2 | 1999 | 599 | 0.040 |
Why?
|
Cell Cycle | 2 | 2007 | 2938 | 0.040 |
Why?
|
Nucleic Acid Hybridization | 5 | 1991 | 1305 | 0.040 |
Why?
|
Macromolecular Substances | 1 | 2002 | 1435 | 0.040 |
Why?
|
Topotecan | 2 | 1997 | 131 | 0.040 |
Why?
|
Pneumonia, Viral | 5 | 1991 | 3241 | 0.040 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 1991 | 1056 | 0.040 |
Why?
|
Perylene | 1 | 1999 | 22 | 0.040 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2005 | 1244 | 0.040 |
Why?
|
Gene Silencing | 1 | 2005 | 1503 | 0.040 |
Why?
|
Mutant Proteins | 2 | 2011 | 489 | 0.040 |
Why?
|
Endogenous Retroviruses | 1 | 2000 | 112 | 0.040 |
Why?
|
Mortality | 1 | 2010 | 2917 | 0.040 |
Why?
|
Arabinofuranosyluracil | 1 | 1998 | 10 | 0.040 |
Why?
|
Binding, Competitive | 1 | 2000 | 1142 | 0.040 |
Why?
|
RNA Interference | 1 | 2007 | 2836 | 0.040 |
Why?
|
Hepatitis B Surface Antigens | 4 | 1986 | 294 | 0.040 |
Why?
|
Zinc Fingers | 1 | 2000 | 577 | 0.040 |
Why?
|
Virion | 1 | 1980 | 430 | 0.040 |
Why?
|
Cross Infection | 2 | 1984 | 1426 | 0.040 |
Why?
|
Receptors, Interleukin-2 | 2 | 1997 | 564 | 0.040 |
Why?
|
Travel | 1 | 2003 | 800 | 0.040 |
Why?
|
Serum Amyloid A Protein | 1 | 1997 | 128 | 0.040 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2007 | 1901 | 0.040 |
Why?
|
Interferon Type I | 4 | 1989 | 569 | 0.040 |
Why?
|
Methionine | 1 | 1999 | 573 | 0.030 |
Why?
|
Hepatitis B Antibodies | 3 | 1986 | 156 | 0.030 |
Why?
|
Cocaine | 1 | 2002 | 960 | 0.030 |
Why?
|
Membrane Fusion | 1 | 1998 | 265 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2007 | 2812 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2007 | 2911 | 0.030 |
Why?
|
HIV Envelope Protein gp41 | 1 | 1998 | 306 | 0.030 |
Why?
|
Laboratories | 1 | 2000 | 463 | 0.030 |
Why?
|
Drug Therapy, Combination | 4 | 2007 | 6318 | 0.030 |
Why?
|
Giant Cells | 1 | 1996 | 187 | 0.030 |
Why?
|
Virulence | 2 | 2011 | 1298 | 0.030 |
Why?
|
Gene Expression Regulation | 3 | 1988 | 11918 | 0.030 |
Why?
|
Receptors, CCR5 | 1 | 1998 | 491 | 0.030 |
Why?
|
Glycoproteins | 2 | 1982 | 2204 | 0.030 |
Why?
|
Fever | 1 | 2003 | 1620 | 0.030 |
Why?
|
Immediate-Early Proteins | 1 | 1998 | 444 | 0.030 |
Why?
|
Disease Models, Animal | 6 | 2009 | 18362 | 0.030 |
Why?
|
Latex Fixation Tests | 1 | 1995 | 29 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2003 | 1728 | 0.030 |
Why?
|
Cricetinae | 3 | 2000 | 2423 | 0.030 |
Why?
|
Mice, Inbred DBA | 5 | 1989 | 624 | 0.030 |
Why?
|
HeLa Cells | 2 | 2000 | 3088 | 0.030 |
Why?
|
Research | 1 | 2003 | 1981 | 0.030 |
Why?
|
Cell Survival | 3 | 1997 | 5792 | 0.030 |
Why?
|
Time Factors | 12 | 2007 | 40272 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1999 | 2750 | 0.030 |
Why?
|
Neoplasm Proteins | 1 | 2007 | 3610 | 0.030 |
Why?
|
Molecular Probe Techniques | 1 | 1995 | 111 | 0.030 |
Why?
|
Lymphocyte Activation | 3 | 1991 | 5496 | 0.030 |
Why?
|
Zalcitabine | 1 | 1994 | 43 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 4588 | 0.030 |
Why?
|
Recombinant Proteins | 6 | 1993 | 6510 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2011 | 22355 | 0.030 |
Why?
|
Transcription Factors | 2 | 2007 | 12166 | 0.030 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 1998 | 545 | 0.030 |
Why?
|
DNA Primers | 1 | 1998 | 2825 | 0.030 |
Why?
|
HIV Envelope Protein gp120 | 1 | 1998 | 925 | 0.030 |
Why?
|
Interleukin-1 | 1 | 1997 | 1251 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2002 | 2886 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2007 | 4936 | 0.030 |
Why?
|
Restriction Mapping | 2 | 1993 | 849 | 0.030 |
Why?
|
Models, Biological | 2 | 2009 | 9493 | 0.030 |
Why?
|
Fibroblasts | 2 | 2003 | 4177 | 0.030 |
Why?
|
Receptors, CXCR4 | 1 | 1998 | 729 | 0.030 |
Why?
|
Genetic Vectors | 3 | 2005 | 3413 | 0.030 |
Why?
|
Colitis | 2 | 1993 | 1244 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1996 | 1682 | 0.030 |
Why?
|
Proteins | 2 | 2007 | 6006 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2009 | 3431 | 0.030 |
Why?
|
Naphthoquinones | 1 | 1993 | 59 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2003 | 20224 | 0.030 |
Why?
|
Selection, Genetic | 1 | 1997 | 877 | 0.030 |
Why?
|
Drug Administration Schedule | 3 | 2009 | 4859 | 0.030 |
Why?
|
Simian immunodeficiency virus | 1 | 1998 | 814 | 0.030 |
Why?
|
Blood Donors | 1 | 1995 | 344 | 0.030 |
Why?
|
Hepatitis B Vaccines | 4 | 1986 | 178 | 0.030 |
Why?
|
DNA-Binding Proteins | 3 | 2000 | 9614 | 0.030 |
Why?
|
DNA, Recombinant | 1 | 1993 | 455 | 0.030 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1992 | 189 | 0.030 |
Why?
|
RNA, Antisense | 1 | 1992 | 136 | 0.030 |
Why?
|
Point Mutation | 1 | 1997 | 1594 | 0.030 |
Why?
|
Middle Aged | 15 | 2009 | 223491 | 0.020 |
Why?
|
Exodeoxyribonucleases | 1 | 1993 | 191 | 0.020 |
Why?
|
Administration, Topical | 3 | 1984 | 703 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2007 | 5800 | 0.020 |
Why?
|
Curcumin | 1 | 1993 | 97 | 0.020 |
Why?
|
Transfection | 1 | 2000 | 5764 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1997 | 1339 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2009 | 10776 | 0.020 |
Why?
|
Chemokine CXCL1 | 1 | 1992 | 102 | 0.020 |
Why?
|
Genotype | 3 | 2003 | 13042 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2011 | 4646 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 1997 | 2106 | 0.020 |
Why?
|
Retinitis | 1 | 1991 | 36 | 0.020 |
Why?
|
Clinical Trials as Topic | 8 | 1995 | 8051 | 0.020 |
Why?
|
Peripheral Nervous System Diseases | 1 | 1996 | 716 | 0.020 |
Why?
|
Seizures | 1 | 2003 | 3000 | 0.020 |
Why?
|
Eye Infections, Viral | 1 | 1991 | 60 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1994 | 892 | 0.020 |
Why?
|
T-Phages | 1 | 1990 | 90 | 0.020 |
Why?
|
Kinetics | 4 | 1993 | 6333 | 0.020 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 1992 | 366 | 0.020 |
Why?
|
Substance Abuse, Intravenous | 1 | 1994 | 530 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 1990 | 417 | 0.020 |
Why?
|
Photochemistry | 2 | 1980 | 238 | 0.020 |
Why?
|
Clone Cells | 1 | 1993 | 1671 | 0.020 |
Why?
|
Interferons | 2 | 1984 | 716 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2003 | 13020 | 0.020 |
Why?
|
Alkynes | 1 | 2009 | 327 | 0.020 |
Why?
|
Immunization Schedule | 2 | 1987 | 228 | 0.020 |
Why?
|
Templates, Genetic | 1 | 1988 | 188 | 0.020 |
Why?
|
Recurrence | 7 | 1998 | 8506 | 0.020 |
Why?
|
Drug Evaluation | 2 | 1987 | 642 | 0.020 |
Why?
|
Cyclopropanes | 1 | 2009 | 437 | 0.020 |
Why?
|
Benzoxazines | 1 | 2009 | 321 | 0.020 |
Why?
|
Rhinovirus | 1 | 1989 | 210 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 1996 | 1207 | 0.020 |
Why?
|
Interleukin-6 | 1 | 1997 | 3230 | 0.020 |
Why?
|
Stromal Cells | 1 | 1993 | 1337 | 0.020 |
Why?
|
Heart | 4 | 2002 | 4449 | 0.020 |
Why?
|
Hypnosis | 1 | 1987 | 84 | 0.020 |
Why?
|
Lymphoid Tissue | 1 | 1988 | 446 | 0.020 |
Why?
|
Thailand | 1 | 2007 | 288 | 0.020 |
Why?
|
Retroviridae | 1 | 1989 | 849 | 0.020 |
Why?
|
DNA Repair | 2 | 1987 | 2048 | 0.020 |
Why?
|
Polyethylene Glycols | 2 | 1982 | 1195 | 0.020 |
Why?
|
Haploidy | 1 | 1986 | 127 | 0.020 |
Why?
|
Probability | 1 | 1992 | 2482 | 0.020 |
Why?
|
Cauda Equina | 1 | 1986 | 45 | 0.020 |
Why?
|
Cyclosporins | 1 | 1986 | 216 | 0.020 |
Why?
|
Hematocrit | 1 | 1987 | 625 | 0.020 |
Why?
|
Latin America | 1 | 2007 | 416 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1988 | 1731 | 0.020 |
Why?
|
Spinal Nerve Roots | 1 | 1986 | 122 | 0.020 |
Why?
|
Transplantation | 1 | 1987 | 221 | 0.020 |
Why?
|
Diarrhea | 1 | 1993 | 1320 | 0.020 |
Why?
|
Infusions, Parenteral | 1 | 1986 | 397 | 0.020 |
Why?
|
Influenza A virus | 1 | 1989 | 460 | 0.020 |
Why?
|
Deltaretrovirus | 1 | 1985 | 162 | 0.020 |
Why?
|
Hepatitis B virus | 2 | 1984 | 530 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 1997 | 3857 | 0.020 |
Why?
|
DNA Viruses | 1 | 1985 | 33 | 0.020 |
Why?
|
Gene Deletion | 1 | 1993 | 2673 | 0.020 |
Why?
|
Personnel, Hospital | 2 | 1984 | 285 | 0.020 |
Why?
|
South Africa | 1 | 2011 | 1871 | 0.020 |
Why?
|
Molecular Weight | 4 | 1990 | 2172 | 0.020 |
Why?
|
Deoxyguanosine | 1 | 1985 | 96 | 0.020 |
Why?
|
Immunity | 1 | 1991 | 1003 | 0.020 |
Why?
|
Injections, Intravenous | 2 | 1999 | 1379 | 0.020 |
Why?
|
Kidney | 8 | 1984 | 7064 | 0.020 |
Why?
|
Encephalitis | 1 | 1989 | 441 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1993 | 4622 | 0.010 |
Why?
|
Papillomavirus Vaccines | 1 | 2011 | 497 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 1986 | 607 | 0.010 |
Why?
|
Pneumonia | 1 | 1996 | 2163 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2001 | 13423 | 0.010 |
Why?
|
Epitopes | 1 | 2011 | 2525 | 0.010 |
Why?
|
Complement System Proteins | 2 | 1986 | 738 | 0.010 |
Why?
|
Corynebacterium Infections | 1 | 1984 | 27 | 0.010 |
Why?
|
Centrifugation, Density Gradient | 4 | 1973 | 298 | 0.010 |
Why?
|
Sacrum | 1 | 1986 | 275 | 0.010 |
Why?
|
Pneumonia, Pneumocystis | 1 | 1986 | 242 | 0.010 |
Why?
|
Actins | 1 | 1992 | 2059 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2011 | 4411 | 0.010 |
Why?
|
Heart Valve Prosthesis | 2 | 1984 | 1468 | 0.010 |
Why?
|
Amnion | 1 | 2005 | 202 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 4 | 1990 | 2475 | 0.010 |
Why?
|
Australia | 1 | 2007 | 1265 | 0.010 |
Why?
|
Cohort Studies | 3 | 2003 | 41795 | 0.010 |
Why?
|
DNA Restriction Enzymes | 2 | 1980 | 548 | 0.010 |
Why?
|
Hematopoiesis | 1 | 1993 | 2058 | 0.010 |
Why?
|
Genetic Variation | 2 | 1996 | 6606 | 0.010 |
Why?
|
Tritium | 5 | 1984 | 707 | 0.010 |
Why?
|
Bereavement | 1 | 1987 | 310 | 0.010 |
Why?
|
Mice, Inbred C3H | 3 | 1989 | 915 | 0.010 |
Why?
|
United States | 3 | 2011 | 73150 | 0.010 |
Why?
|
Administration, Oral | 3 | 1999 | 4039 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 1988 | 1727 | 0.010 |
Why?
|
Cesium | 3 | 1971 | 36 | 0.010 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2005 | 235 | 0.010 |
Why?
|
Nucleic Acid Denaturation | 3 | 1973 | 110 | 0.010 |
Why?
|
Goats | 1 | 2003 | 166 | 0.010 |
Why?
|
Lentivirus | 1 | 2005 | 519 | 0.010 |
Why?
|
Immune Sera | 1 | 2003 | 605 | 0.010 |
Why?
|
Keratins | 1 | 1984 | 502 | 0.010 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1986 | 1438 | 0.010 |
Why?
|
Canada | 1 | 2007 | 2139 | 0.010 |
Why?
|
Cytopathogenic Effect, Viral | 2 | 1980 | 152 | 0.010 |
Why?
|
Myocardium | 5 | 2002 | 4788 | 0.010 |
Why?
|
Horses | 1 | 1982 | 296 | 0.010 |
Why?
|
Catheters, Indwelling | 1 | 1984 | 436 | 0.010 |
Why?
|
Adenine | 1 | 2007 | 993 | 0.010 |
Why?
|
Radiation Injuries | 1 | 1989 | 1204 | 0.010 |
Why?
|
Survival | 1 | 2002 | 160 | 0.010 |
Why?
|
Echocardiography | 1 | 1994 | 5044 | 0.010 |
Why?
|
Transcription, Genetic | 3 | 1993 | 7599 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 2002 | 413 | 0.010 |
Why?
|
Placebos | 2 | 1984 | 1668 | 0.010 |
Why?
|
Penicillin G | 1 | 1981 | 40 | 0.010 |
Why?
|
Antibody Specificity | 2 | 1998 | 1065 | 0.010 |
Why?
|
Interferon-gamma | 1 | 1989 | 3164 | 0.010 |
Why?
|
Cardiomyopathy, Dilated | 1 | 1987 | 843 | 0.010 |
Why?
|
HLA Antigens | 1 | 1986 | 1337 | 0.010 |
Why?
|
Prognosis | 3 | 1996 | 30022 | 0.010 |
Why?
|
Epidermis | 1 | 1984 | 539 | 0.010 |
Why?
|
Deoxycytidine | 1 | 1985 | 888 | 0.010 |
Why?
|
Agammaglobulinemia | 1 | 1982 | 174 | 0.010 |
Why?
|
Mice, SCID | 1 | 2005 | 2632 | 0.010 |
Why?
|
Analysis of Variance | 2 | 2005 | 6241 | 0.010 |
Why?
|
Adrenalectomy | 1 | 2002 | 348 | 0.010 |
Why?
|
Arabinonucleotides | 1 | 1979 | 5 | 0.010 |
Why?
|
Vidarabine Phosphate | 1 | 1979 | 11 | 0.010 |
Why?
|
Sheep | 1 | 1982 | 1451 | 0.010 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2001 | 239 | 0.010 |
Why?
|
Chlorides | 3 | 1971 | 663 | 0.010 |
Why?
|
Drug Combinations | 1 | 1986 | 2079 | 0.010 |
Why?
|
Streptococcal Infections | 1 | 1984 | 619 | 0.010 |
Why?
|
Acute Disease | 2 | 2005 | 7242 | 0.010 |
Why?
|
Dermatitis, Phototoxic | 1 | 1999 | 17 | 0.010 |
Why?
|
Binding Sites | 2 | 1993 | 6017 | 0.010 |
Why?
|
Norepinephrine | 1 | 2002 | 900 | 0.010 |
Why?
|
Anthracenes | 1 | 1999 | 83 | 0.010 |
Why?
|
Aged | 8 | 2007 | 171562 | 0.010 |
Why?
|
Leukocytes | 1 | 1987 | 2030 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2009 | 12558 | 0.010 |
Why?
|
Nucleotides | 1 | 1981 | 455 | 0.010 |
Why?
|
Molecular Biology | 3 | 1971 | 573 | 0.010 |
Why?
|
Gene Amplification | 1 | 2003 | 1090 | 0.010 |
Why?
|
Haplorhini | 4 | 1973 | 524 | 0.010 |
Why?
|
Psychotherapy | 1 | 1987 | 1656 | 0.010 |
Why?
|
Uterus | 1 | 1982 | 661 | 0.010 |
Why?
|
Rabbits | 2 | 1987 | 4781 | 0.010 |
Why?
|
Superoxides | 1 | 1979 | 389 | 0.010 |
Why?
|
Random Allocation | 3 | 1989 | 2397 | 0.010 |
Why?
|
DNA, Single-Stranded | 1 | 1980 | 351 | 0.010 |
Why?
|
Blotting, Western | 1 | 2005 | 5037 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 1988 | 2676 | 0.010 |
Why?
|
Leukocyte Count | 2 | 1992 | 1605 | 0.010 |
Why?
|
Temperature | 1 | 1984 | 2235 | 0.010 |
Why?
|
Antibodies | 2 | 1998 | 2425 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2005 | 1602 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 2 | 1998 | 1813 | 0.010 |
Why?
|
Death, Sudden, Cardiac | 1 | 2005 | 1568 | 0.010 |
Why?
|
Herpesvirus 4, Human | 1 | 1982 | 1082 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 1986 | 1885 | 0.010 |
Why?
|
Dimerization | 1 | 1998 | 886 | 0.010 |
Why?
|
Disease Progression | 3 | 2002 | 13646 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2003 | 36849 | 0.010 |
Why?
|
DNA | 4 | 1991 | 7211 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2000 | 1837 | 0.010 |
Why?
|
Treatment Outcome | 5 | 2007 | 65379 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 2005 | 2258 | 0.010 |
Why?
|
Chronic Disease | 2 | 2005 | 9379 | 0.010 |
Why?
|
Postoperative Complications | 2 | 1988 | 15881 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 1984 | 1398 | 0.010 |
Why?
|
Fetus | 1 | 1982 | 1883 | 0.010 |
Why?
|
Centrifugation, Zonal | 2 | 1971 | 14 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 1988 | 4785 | 0.010 |
Why?
|
Genetics, Microbial | 2 | 1971 | 53 | 0.010 |
Why?
|
Genes, pol | 1 | 1993 | 52 | 0.010 |
Why?
|
Phylogeny | 1 | 2001 | 2843 | 0.010 |
Why?
|
Cytosine | 2 | 1973 | 213 | 0.010 |
Why?
|
Sucrose | 2 | 1971 | 159 | 0.010 |
Why?
|
Heart Valve Diseases | 1 | 1981 | 1030 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 1999 | 2862 | 0.010 |
Why?
|
Erythrocytes | 1 | 1982 | 2421 | 0.010 |
Why?
|
Placenta | 1 | 1982 | 1723 | 0.010 |
Why?
|
Liver Diseases | 1 | 1981 | 1304 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 1988 | 4300 | 0.010 |
Why?
|
Organ Size | 2 | 1988 | 2268 | 0.010 |
Why?
|
Spleen | 2 | 1988 | 2296 | 0.010 |
Why?
|
Stress, Psychological | 1 | 1987 | 4543 | 0.010 |
Why?
|
Concanavalin A | 1 | 1991 | 190 | 0.010 |
Why?
|
Patient Compliance | 2 | 1992 | 2693 | 0.010 |
Why?
|
Chymotrypsin | 1 | 1971 | 137 | 0.010 |
Why?
|
Microscopy, Electron | 2 | 1973 | 2559 | 0.010 |
Why?
|
HIV Envelope Protein gp160 | 1 | 1991 | 96 | 0.010 |
Why?
|
Phosphorus Isotopes | 1 | 1970 | 125 | 0.010 |
Why?
|
Adolescent | 4 | 2007 | 89184 | 0.010 |
Why?
|
Colony-Forming Units Assay | 1 | 1991 | 351 | 0.010 |
Why?
|
Hepatitis A | 1 | 1971 | 127 | 0.010 |
Why?
|
Lung Diseases | 1 | 1981 | 1925 | 0.010 |
Why?
|
Capsules | 1 | 1991 | 193 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1988 | 10267 | 0.010 |
Why?
|
Open Reading Frames | 1 | 1993 | 812 | 0.010 |
Why?
|
Gene Products, env | 1 | 1991 | 250 | 0.010 |
Why?
|
DNA Probes | 1 | 1991 | 542 | 0.010 |
Why?
|
Mice, Inbred Strains | 2 | 1983 | 1769 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2005 | 10478 | 0.010 |
Why?
|
Skin | 1 | 2003 | 4499 | 0.010 |
Why?
|
Platinum | 1 | 1971 | 222 | 0.010 |
Why?
|
Risk | 2 | 1996 | 9636 | 0.010 |
Why?
|
Mutagenesis | 1 | 1993 | 1229 | 0.010 |
Why?
|
Deoxyribonuclease BamHI | 1 | 1988 | 17 | 0.010 |
Why?
|
Biopsy | 2 | 1993 | 6808 | 0.010 |
Why?
|
Deoxyribonuclease EcoRI | 1 | 1988 | 30 | 0.010 |
Why?
|
Sequence Deletion | 1 | 1993 | 1497 | 0.010 |
Why?
|
Genetic Markers | 1 | 1995 | 2604 | 0.000 |
Why?
|
Virus Cultivation | 3 | 1973 | 88 | 0.000 |
Why?
|
Neutropenia | 1 | 1994 | 893 | 0.000 |
Why?
|
Hot Temperature | 2 | 1973 | 1440 | 0.000 |
Why?
|
Oxygen | 1 | 1980 | 4273 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 2003 | 14737 | 0.000 |
Why?
|
Arthritis, Infectious | 1 | 1971 | 347 | 0.000 |
Why?
|
Lectins | 1 | 1989 | 490 | 0.000 |
Why?
|
Autoimmune Diseases | 1 | 1980 | 2257 | 0.000 |
Why?
|
Drug Resistance | 1 | 1993 | 1595 | 0.000 |
Why?
|
Endomyocardial Fibrosis | 1 | 1987 | 41 | 0.000 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1989 | 896 | 0.000 |
Why?
|
Phytohemagglutinins | 1 | 1987 | 165 | 0.000 |
Why?
|
Carbon | 1 | 1971 | 672 | 0.000 |
Why?
|
Follow-Up Studies | 3 | 1999 | 39407 | 0.000 |
Why?
|
Sex Factors | 1 | 1981 | 10654 | 0.000 |
Why?
|
Carbon Isotopes | 3 | 1973 | 458 | 0.000 |
Why?
|
Protein Precursors | 1 | 1991 | 1134 | 0.000 |
Why?
|
Immunity, Maternally-Acquired | 1 | 1987 | 112 | 0.000 |
Why?
|
Maus Elberfeld virus | 1 | 1986 | 5 | 0.000 |
Why?
|
Lymphokines | 1 | 1989 | 927 | 0.000 |
Why?
|
Liver | 1 | 1982 | 7574 | 0.000 |
Why?
|
Sarcoma, Kaposi | 1 | 1989 | 374 | 0.000 |
Why?
|
Vaccines, Attenuated | 1 | 1987 | 314 | 0.000 |
Why?
|
Mouth Mucosa | 1 | 1989 | 437 | 0.000 |
Why?
|
Infant | 1 | 1988 | 36510 | 0.000 |
Why?
|
Cell Communication | 1 | 1993 | 1660 | 0.000 |
Why?
|
Chemical Precipitation | 1 | 1985 | 175 | 0.000 |
Why?
|
Antigens | 1 | 1971 | 1443 | 0.000 |
Why?
|
Myosins | 1 | 1987 | 407 | 0.000 |
Why?
|
Immunoblotting | 1 | 1988 | 1647 | 0.000 |
Why?
|
Hepatitis B Core Antigens | 1 | 1985 | 90 | 0.000 |
Why?
|
Colonoscopy | 1 | 1993 | 1412 | 0.000 |
Why?
|
Mice, Inbred ICR | 1 | 1985 | 363 | 0.000 |
Why?
|
Herpesvirus 3, Human | 1 | 1985 | 159 | 0.000 |
Why?
|
Phosphorus Radioisotopes | 1 | 1984 | 100 | 0.000 |
Why?
|
Drug Contamination | 1 | 1985 | 151 | 0.000 |
Why?
|
Age Factors | 1 | 1981 | 18471 | 0.000 |
Why?
|
Antigens, Bacterial | 1 | 1989 | 1150 | 0.000 |
Why?
|
Infant, Newborn | 2 | 2000 | 26411 | 0.000 |
Why?
|
Atrophy | 1 | 1988 | 1648 | 0.000 |
Why?
|
Statistics as Topic | 1 | 1989 | 2363 | 0.000 |
Why?
|
Rodent Diseases | 1 | 1983 | 53 | 0.000 |
Why?
|
Antibodies, Monoclonal | 2 | 1990 | 9261 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1986 | 20765 | 0.000 |
Why?
|
Immunization, Secondary | 1 | 1985 | 372 | 0.000 |
Why?
|
Survival Analysis | 1 | 1995 | 10117 | 0.000 |
Why?
|
Isoenzymes | 1 | 1987 | 1684 | 0.000 |
Why?
|
Boston | 2 | 1985 | 9371 | 0.000 |
Why?
|
Culture Techniques | 2 | 1973 | 530 | 0.000 |
Why?
|
Necrosis | 1 | 1986 | 1621 | 0.000 |
Why?
|
Purine Nucleotides | 1 | 1981 | 27 | 0.000 |
Why?
|
Mesocricetus | 1 | 1981 | 256 | 0.000 |
Why?
|
Escherichia coli | 1 | 1993 | 4211 | 0.000 |
Why?
|
Virus Activation | 1 | 1983 | 322 | 0.000 |
Why?
|
Bone Marrow | 1 | 1991 | 2929 | 0.000 |
Why?
|
Pregnancy | 1 | 1982 | 30200 | 0.000 |
Why?
|
Ointments | 1 | 1979 | 58 | 0.000 |
Why?
|
Convalescence | 1 | 1978 | 109 | 0.000 |
Why?
|
Immunologic Memory | 1 | 1985 | 1374 | 0.000 |
Why?
|
Autoantibodies | 1 | 1987 | 2126 | 0.000 |
Why?
|
Survival Rate | 1 | 1992 | 12870 | 0.000 |
Why?
|
Embryo, Mammalian | 1 | 1984 | 1674 | 0.000 |
Why?
|
Cisplatin | 1 | 1984 | 1661 | 0.000 |
Why?
|
Risk Factors | 2 | 1995 | 74962 | 0.000 |
Why?
|
Monocytes | 1 | 1987 | 2595 | 0.000 |
Why?
|
Calcinosis | 1 | 1986 | 1481 | 0.000 |
Why?
|
Neutralization Tests | 1 | 1978 | 739 | 0.000 |
Why?
|
Quality of Life | 1 | 1998 | 13503 | 0.000 |
Why?
|
Phosphorylation | 1 | 1987 | 8326 | 0.000 |
Why?
|
Body Weight | 1 | 1986 | 4629 | 0.000 |
Why?
|
Lung | 2 | 1984 | 10089 | 0.000 |
Why?
|
Child | 1 | 1982 | 80891 | 0.000 |
Why?
|
Immune Tolerance | 1 | 1982 | 2324 | 0.000 |
Why?
|
Vaccination | 1 | 1984 | 3431 | 0.000 |
Why?
|
Hepatitis B Antigens | 1 | 1971 | 38 | 0.000 |
Why?
|
Histocompatibility Antigens | 1 | 1973 | 478 | 0.000 |
Why?
|
Genetic Code | 1 | 1971 | 139 | 0.000 |
Why?
|
Uridine | 1 | 1971 | 135 | 0.000 |
Why?
|
Neoplasms | 1 | 1980 | 22385 | 0.000 |
Why?
|
Hematuria | 1 | 1971 | 233 | 0.000 |
Why?
|
Erythema | 1 | 1971 | 261 | 0.000 |
Why?
|
Liver Function Tests | 1 | 1971 | 526 | 0.000 |
Why?
|
Aspartate Aminotransferases | 1 | 1971 | 414 | 0.000 |
Why?
|
Antigen-Antibody Complex | 1 | 1971 | 513 | 0.000 |
Why?
|
Synovial Fluid | 1 | 1971 | 393 | 0.000 |
Why?
|
Pain | 1 | 1984 | 5103 | 0.000 |
Why?
|
Mass Screening | 1 | 1984 | 5451 | 0.000 |
Why?
|
Retrospective Studies | 1 | 1995 | 81801 | 0.000 |
Why?
|
Aging | 1 | 1984 | 8764 | 0.000 |
Why?
|
Prospective Studies | 1 | 1989 | 54920 | 0.000 |
Why?
|
RNA | 1 | 1971 | 2726 | 0.000 |
Why?
|
Brain | 1 | 1987 | 27454 | 0.000 |
Why?
|